| Literature DB >> 35878307 |
Fabiana Clérigo1, Sandra Ferreira1, Carina Ladeira1,2, Ana Marques-Ramos1, Marina Almeida-Silva1,3, Luís André Mendes1,4.
Abstract
Emerging contaminants such as nanoplastics (NPs), as well as manufacturing by-products such as plasticizers, have gained global attention and concern due to their limited biodegradability and their potential impact on human health, in particular the effects on respiratory tissue. In parallel, in vitro cell culture techniques are key to the assessment and characterization of toxic effects and cellular mechanisms in different types of tissues and should provide relevant information to understand the hazardous potential of these emergent contaminants. This systematic review presents the main results on the current knowledge of the effects of NPs and plasticizers on lung cells, as assessed with the use of in vitro cell culture techniques. From the selected studies (n = 10), following the PRISMA approach, it was observed that cell viability was the most frequently assessed endpoint and that most studies focused on epithelial cells and exposures to polystyrene (PS). It was observed that exposure to NPs or plasticizers induces cytotoxicity in a dose-dependent manner, regardless of the size of the NPs. Furthermore, there is evidence that the characteristics of NPs can affect the toxic response by promoting the association with other organic compounds. As such, further in vitro studies focusing on the combination of NPs with plasticizers will be essential for the understanding of mechanisms of NPs toxicity.Entities:
Keywords: cytotoxicity; in vitro; lung cells; nanoplastics; plasticizers
Year: 2022 PMID: 35878307 PMCID: PMC9315584 DOI: 10.3390/toxics10070402
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
PEO criteria for inclusion and exclusion in the systematic review.
| PEO | Inclusion Criteria | Exclusion Criteria |
|---|---|---|
| Population | Cohorts, cross-sectional and | |
| Exposure | Nanoplastics (up to 1000 nm in diameter), plasticizers | Microplastics (>1000 nm) |
| Outcome | Cell viability, cell morphology, cell fate, DNA damage and protein expression |
Figure 1Summary of the inclusion and screening of articles following the PRISMA approach [30].
List of papers reviewed clustered according to exposure type and the main findings.
| Exposure | Main Findings | References | |||||
|---|---|---|---|---|---|---|---|
| Contaminant Type | Cell Type | Cell | Cell | DNA | Protein | ||
| NPs | PS | A549 | ✔ | ✔ | ✔ | ✔ | [ |
| ✔ | ✔ | ✔ | [ | ||||
| ✔ | [ | ||||||
| ✔ | [ | ||||||
| BEAS-2B | ✔ | ✔ | ✔ | [ | |||
| ✔ | ✔ | [ | |||||
| HPAEpiC | ✔ | ✔ | [ | ||||
| Plasticizers | MEHP, DEHP | A549 | ✔ | ✔ | ✔ | [ | |
| DBP | A549 | ✔ | ✔ | [ | |||
| NPs + Plasticizers | PS + DEHP, DBP | A549 | ✔ | [ | |||
| PVC + DEHP, DIOP | WI38va13 | ✔ | [ | ||||
DBP—Dibutyl phthalate; DEHP—Di(2-ethylhexyl)phthalate; DIOP—2,3-O-isopropylidene-2,3-dihydroxy-1,4-bis (diphenylphosphino)butane; MEHP—Mono-2-ethylhexyl phthalate; PS—Polystyrene; PVC—Polyvinyl chloride.
Figure 2NPs’ sizes (nm) from the studies included for review: 25 and 70 nm [31]; 40 nm [17]; 50 nm [32]; 60 to 75 nm [35]; 116 nm [20]; 190 nm [33,34] Upper limit of 1000 nm defined based on reviewed literature [8].
Cell viability effects by concentration range and contaminant (NPs, plasticizers or both).
| Contaminant Type | Cell | Exposure Time | Concentration Range | Cell Viability | Reference |
|---|---|---|---|---|---|
| NPs | A549 | 24 h | 2.5–30 μg/mL | No significant changes at <5 μg/mL | [ |
| 10–300 μg/mL | Significant effects at >160 μg/mL | [ | |||
| 500 μg/mL | No significant effects | [ | |||
| BEAS-2B | 24 h | 0–100 μg/mL | Significantly inhibition at >10 μg/mL | [ | |
| 0–40 μg/cm2 | Significantly inhibition at >10 μg/cm2 | [ | |||
| HPAEpiC | 24 h | 0–40 μg/cm2 | Significantly inhibition at >15μg/cm2 | [ | |
| Plasticizers | A549 | 4 h–24 h | 0–1000 µM MEHP | 70% reduction at 100 and 1000 µM for MEHP and significant difference at 10–1000 μM | [ |
| 24 h–48 h | 0–1000 µM MEHP | Significant difference at 5–1000 μM for MEHP | [ | ||
| 0–20 ng/cm2 DBP | No significant changes observed | [ | |||
| NPs + Plasticizers | A549 | 24 h | 0–1000 µg/mL NPs | Significant effects at >200 μg/mL for NPs and at 5 μg/mL for plasticizers | [ |